{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T17:13:14Z","timestamp":1698685994761},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1007\/s12149-007-0129-5","type":"journal-article","created":{"date-parts":[[2008,7,3]],"date-time":"2008-07-03T14:24:05Z","timestamp":1215095045000},"page":"357-362","source":"Crossref","is-referenced-by-count":3,"title":["Does cisplatin chemotherapy decrease the MDP uptake of normal bone? An experimental study"],"prefix":"10.1007","volume":"22","author":[{"given":"Ozhan","family":"Ozdogan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Turkan","family":"Ertay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gulhan","family":"Arslan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali R.","family":"Sisman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gamze","family":"Capa Kaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osman","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Canan","family":"\u00c7oker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ataman","family":"Gure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hatice","family":"Durak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,7,4]]},"reference":[{"key":"129_CR1","first-page":"1185","volume":"21","author":"M.D. Francis","year":"1980","unstructured":"Francis MD, Ferguson DL, Tofe AJ, Bevan JA, Michaels SE. Comparative evaluation of three diphosphonates: in vitro adsorption (C-14 labeled) and in vivo osteogenic uptake (Tc-99m complexed). J Nucl Med 1980;21:1185\u20131189.","journal-title":"J Nucl Med"},{"key":"129_CR2","first-page":"199","volume":"48","author":"K.J. Murphy","year":"1997","unstructured":"Murphy KJ, Line BR, Malfetano J. Etidronate therapy decreases the sensitivity of bone scanning with methylene diphosphonate labeled with technetium-99m. Can Assoc Radiol J 1997;48:199\u2013202.","journal-title":"Can Assoc Radiol J"},{"key":"129_CR3","first-page":"559","volume":"11","author":"T. Boulikas","year":"2004","unstructured":"Boulikas T, Vougiouka M. Recent clinical trials using cisplatin, carboplatin and their combination chemotherapy drugs (review). Oncol Rep 2004;11:559\u2013595.","journal-title":"Oncol Rep"},{"key":"129_CR4","first-page":"187","volume":"94","author":"H.P. Lipp","year":"2005","unstructured":"Lipp HP, Hartmann JT. Platinum compounds: metabolism, toxicity and supportive strategies. Schweiz Rundsch Med Prax 2005;94:187\u2013198.","journal-title":"Schweiz Rundsch Med Prax"},{"key":"129_CR5","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0162-0134(90)80068-9","volume":"40","author":"L.L. Slavin","year":"1990","unstructured":"Slavin LL, Bose RN. Phosphonato complexes of platinium(II): kinetics of formation and phosphorus-31 NMR characterization studies. J Inorg Biochem 1990;40:339\u2013347.","journal-title":"J Inorg Biochem"},{"key":"129_CR6","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/00004424-198309000-00013","volume":"18","author":"J.G. McAfee","year":"1983","unstructured":"McAfee JG, Singh A, Roskopf M, Ritter C, Lyons B, Schoonmaker JE, et al. Experimental drug induced changes in renal function and biodistribution of 99mTc-MDP. Invest Radiol 1983;18:470\u2013478.","journal-title":"Invest Radiol"},{"key":"129_CR7","first-page":"1294","volume":"68","author":"Y. Nakayama","year":"1992","unstructured":"Nakayama Y, Okuno S, Miki T, Nishizawa Y, Morii H. A case of esophageal carcinoma with hypercalcemia caused by PTH-rP: the effect of therapy on the bone and calcium metabolism. Nippon Naibunpi Gakkai Zasshi 1992;68:1294\u20131299.","journal-title":"Nippon Naibunpi Gakkai Zasshi"},{"key":"129_CR8","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.surg.2005.03.024","volume":"138","author":"J.W. Suliburk","year":"2005","unstructured":"Suliburk JW, Helmer KS, Gonzalez EA, Robinson EK, Mercer DW. Ketamine attenuates liver injury attributed to endotoxemia: role of cyclooxygenase-2. Surgery 2005;138:134\u2013140.","journal-title":"Surgery"},{"key":"129_CR9","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1053\/jpsu.2001.24742","volume":"36","author":"K.U. Ozkan","year":"2001","unstructured":"Ozkan KU, Kucukaydin M, Muhtaroglu S, Kontas O. Evaluation of contralateral testicular damage after unilateral testicular torsion by serum inhibin B levels. J Pediatr Surg 2001;36:1050\u20131053.","journal-title":"J Pediatr Surg"},{"key":"129_CR10","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.ejca.2005.02.019","volume":"41","author":"E. Fonseca","year":"2005","unstructured":"Fonseca E, Grau JJ, Sastre J, Garc\u00eda-G\u00f3mez JM, Rueda A, Pastor M, et al. Induction chemotherapy with cisplatin\/docetaxel versus cisplatin\/5-fluorouracil for locally advanced squamous cell carcinoma of the head and neck: a randomised phase II study. Eur J Cancer 2005;41:1254\u20131260.","journal-title":"Eur J Cancer"},{"key":"129_CR11","first-page":"219","volume":"50","author":"E.J. Freireich","year":"1966","unstructured":"Freireich EJ, Gehan EA, Rall DP, Schmidt LH, Skipper HE. Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chemother Rep 1966;50:219\u2013244.","journal-title":"Cancer Chemother Rep"},{"key":"129_CR12","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1006\/gyno.1993.1184","volume":"50","author":"T.L. Cornelison","year":"1993","unstructured":"Cornelison TL, Reed E. Nephrotoxicity and hydration management for cisplatin, carboplatin, and ormaplatin. Gynecol Oncol 1993;50:147\u2013158.","journal-title":"Gynecol Oncol"},{"key":"129_CR13","first-page":"389","volume":"19","author":"S.M. Hopfer","year":"1989","unstructured":"Hopfer SM, Ziebka L, Sunderman FW Jr, Sporn JR, Greenberg BR. Direct analysis of platinum in plasma and urine by electrothermal atomic absorption spectrophotometry. Ann Clin Lab Sci 1989;19:389\u2013396.","journal-title":"Ann Clin Lab Sci"},{"key":"129_CR14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00006231-199201000-00010","volume":"13","author":"A. D\u2019Addabbo","year":"1992","unstructured":"D\u2019Addabbo A, Rubini G, Mele M, Lauriero F. A new method for assessing 99Tcm-MDP bone uptake from a bone scan image: quantitative measurement of radioactivity in global skeletal regions of interest. Nucl Med Commun 1992;13:55\u201360.","journal-title":"Nucl Med Commun"},{"key":"129_CR15","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/BF01146854","volume":"16","author":"J.A. Raymakers","year":"1990","unstructured":"Raymakers JA, Savelkoul TJ, Hoekstra A, Visser WJ, van Rijk PP, Duursma SA. The value of local 99mTc(Sn)-MDP bone to soft tissue uptake ratio in osteoporosis, before and during fluoride therapy. Eur J Nucl Med 1990;16:157\u2013160.","journal-title":"Eur J Nucl Med"},{"key":"129_CR16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.lungcan.2006.11.017","volume":"56","author":"Y.M. Chen","year":"2007","unstructured":"Chen YM, Yu CJ, Yang CH, Perng RP, Tsai CM, Shih JF, et al. A phase II study of oral vinorelbine in combination with cisplatin conducted in Taiwan in patients with unresectable localized or metastatic non-small cell lung carcinoma. Lung Cancer 2007;56:89\u201395.","journal-title":"Lung Cancer"},{"key":"129_CR17","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.eururo.2004.11.013","volume":"47","author":"I. Kausch","year":"2005","unstructured":"Kausch I, Jiang H, Thode B, Doehn C, Kruger S, Jocham D. Inhibition of bcl-2 enhances the efficacy of chemotherapy in renal cell carcinoma. Eur Urol 2005;47:703\u2013709.","journal-title":"Eur Urol"},{"key":"129_CR18","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1023\/A:1005770405844","volume":"31","author":"R. Mastrangelo","year":"1997","unstructured":"Mastrangelo R, Tornesello A, Lasorella A, Iavarone A, Mastrangelo S, Riccardi R, et al. Optimal use of the 131-Imetaiodobenzylguanidine and cisplatin combination in advanced neuroblastoma. J Neurooncol 1997;31:153\u2013158.","journal-title":"J Neurooncol"},{"key":"129_CR19","first-page":"1221","volume":"33","author":"T. Sato","year":"1996","unstructured":"Sato T, Yoshioka S, Ogata Y, Abe Y, Takahashi J, Yamada K, et al. Analysis of contributing factors with high renal uptake of 99mTc-MDP after anti-cancer chemotherapy including cisplatin. Kaku Igaku 1996;33:1221\u20131226.","journal-title":"Kaku Igaku"},{"key":"129_CR20","first-page":"1017","volume":"49","author":"H. Igari","year":"1989","unstructured":"Igari H, Yamada K, Fuziwara T, Watai K, Kakei M, Matsui K, et al. Renal accumulation of technetium-99m-labeled bone imaging agents in patients treated with cisplatin (in Japanese). Nippon Igaku Hoshasen Gakkai Zasshi 1989;49:1017\u20131024.","journal-title":"Nippon Igaku Hoshasen Gakkai Zasshi"},{"key":"129_CR21","first-page":"13","volume-title":"Textbook of nuclear medicine","author":"M.A. Wilson","year":"1997","unstructured":"Wilson MA. Musculoskeletal system. In: Wilson MA, editor. Textbook of nuclear medicine. Philadelphia: Lippincott-Raven; 1997. p. 13."},{"key":"129_CR22","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/00006231-198606000-00004","volume":"7","author":"J. Fruhling","year":"1986","unstructured":"Fruhling J, Verbist A, Balikdjian D. Which diphosphonate for routine bone scintigraphy (MDP, HDP or DPD)? Nucl Med Commun 1986;7:415\u2013425.","journal-title":"Nucl Med Commun"},{"key":"129_CR23","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/01.sla.0000218089.61635.5f","volume":"244","author":"P. Esquis","year":"2006","unstructured":"Esquis P, Consolo D, Magnin G, Pointaire P, Moretto P, Ynsa MD, et al. High intra-abdominal pressure enhances the penetration and antitumor effect of intraperitoneal cisplatin on experimental peritoneal carcinomatosis. Ann Surg 2006;244:106\u2013112.","journal-title":"Ann Surg"},{"key":"129_CR24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.heares.2004.02.007","volume":"193","author":"D. Thomas Dickey","year":"2004","unstructured":"Thomas Dickey D, Muldoon LL, Kraemer DF, Neuwelt EA. Protection against cisplatin-induced ototoxicity by N-acetylcysteine in a rat model. Hear Res 2004;193:25\u201330.","journal-title":"Hear Res"},{"key":"129_CR25","unstructured":"Food and Drug Administration. Oncology Tools. Center of Drug Evaluation and Research. 2008-05-05. http:\/\/www.fda.gov\/cder\/cancer\/aminalframe.htm . Accessed 5 May 2008."},{"key":"129_CR26","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.bcp.2005.09.020","volume":"70","author":"A. Yonezawa","year":"2005","unstructured":"Yonezawa A. Association between tubular toxicity of cisplatin and expression of organic cation transporter rOCT2 (Slc22a2) in the rat. Biochem Pharmacol 2005;70:1823\u20131831.","journal-title":"Biochem Pharmacol"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-007-0129-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12149-007-0129-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-007-0129-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T04:41:47Z","timestamp":1559450507000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12149-007-0129-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["129"],"URL":"https:\/\/doi.org\/10.1007\/s12149-007-0129-5","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}